Current stock page

Catalysts

KURA Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

KURAKura Oncology, Inc.

Healthcare / Biotechnology

Low Priority

In Line With Peers

BearishEdge 4/10
$7.77+$0.34 (+4.58%)

Latest quote

  • Momentum
    40
  • Value
    70
  • Quality
    45
  • Risk resilience
    39
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Mar 4, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 47/100

Momentum 40/100 and sentiment — before the next covered event.

Recent coverage
3 articles

Updated Nov 15, 2026 · Sentiment 17.03%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 40/100AIQ Edge 4/10 In Line With Peers
Beat rate
50%
4 of 8 reported periods
Average surprise
-77.2%
Across covered historical reports
Latest result
+4.8%
Nov 10, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 10, 2026—-$0.82-$0.78+4.8%$24.94M$22.84M
Aug 12, 2026—-$0.88-$0.77+12.2%$20.16M$20.87M
May 12, 2026—-$0.88-$0.83+5.7%$25.97M$18.27M
Mar 5, 2026—-$0.72-$0.92-27.8%$35.43M$17.34M
Nov 4, 2025—-$0.57-$0.85-49.1%$51.43M$20.75M
Aug 7, 2025—$0.15-$0.75-600.0%$64.95M$15.29M
May 1, 2025—-$0.51-$0.66-29.4%$66.66M$14.11M
Feb 26, 2025—-$0.65-$0.22+66.2%$57.96M$53.88M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
15
Buy
1
Hold
12-month analyst target
$24.00
+208.88% versus current price
Based on 16 analyst observations. Targets are estimates, not predictions.
Low target
$24.00
+208.88% vs latest price
Average target
$24.00
+208.88% vs latest price
High target
$24.00
+208.88% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateMar 4, 2027

Next known earnings or reporting date.

EPS estimate-$0.86

Current analyst expectation for the upcoming report.

Revenue estimate$27.25M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score40

Where event reaction would show up first.

AIQ score47/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
16
Average target
$24.00
Target upside
208.88%
Target range
$24.00 - $24.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
2
Negative
0
seekingalpha.com · Nov 13, 2026

Kura Oncology, Inc. 2026 Q3 - Results - Earnings Call Presentation

2026-11-13. The following slide deck was published by Kura Oncology, Inc.

finance.yahoo.com · Aug 25, 2026

Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?

Wilson's purchase increases his total equity stake by 9% following a 62% one-year stock return, signaling confidence in the oncology biotech's pipeline.

rttnews.com · Aug 25, 2026

5 After-Hours Healthcare Gainers: AMIX, PMI, TENX, KURA, NEPH

The after-hours gainers on Monday included Autonomix Medical, following its recent reverse stock split; Picard Medical, which reported encouraging Q2 results recently; and Tenax Therapeutics, now showing signs of recovery after plunging 90% earlier this month, among others.

Open full news and sentiment

KURA Catalysts FAQ

What are the next catalysts for KURA stock?

KURA's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move KURA stock?

Upcoming events that could move KURA include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could KURA's next earnings report affect the stock?

KURA's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive KURA stock higher?

KURA could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt KURA stock?

KURA could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.